Research Article
Expression and Clinical Significance of ILF2 in Gastric Cancer
Table 1
Relationship between ILF2 expression and clinicopathological parameters (
).
| Parameters | ILF2 expression | High () | Low () | X2 | value |
| Gender | | | | | Male | 21 | 13 | 0.000 | 0.986 | Female | 16 | 10 | | | Age (years) | | | | | >60 | 19 | 14 | 0.519 | 0.471 | ≤60 | 18 | 9 | | | Location | | | | | Cardia | 19 | 12 | 0.004 | 0.951 | Body/antrum | 18 | 11 | | | Size (cm) | | | | | >5 | 13 | 9 | 0.097 | 0.755 | ≤5 | 24 | 14 | | | Histological differentiation | | | | | Well/moderate | 7 | 15 | 13.092 | 0.000 | Poor/not | 30 | 8 | | | Depth of invasion (T classification) | | | | | T1/T2 | 6 | 9 | 3.972 | 0.046 | T3/T4 | 31 | 14 | | | Lymph node metastasis | | | | | No | 10 | 14 | 6.769 | 0.009 | Yes | 27 | 9 | | | Surgical resection | | | | | Partial | 10 | 7 | 0.081 | 0.776 | Total | 27 | 16 | | | TNM stage | | | | | I/II | 9 | 16 | 11.944 | 0.001 | III/IV | 28 | 7 | | | CA19-9 | | | | | Positive | 13 | 6 | 0.537 | 0.464 | Negative | 24 | 17 | | | CEA | | | | | Positive | 13 | 7 | 0.141 | 0.707 | Negative | 24 | 16 | | | CA125 | | | | | Positive | 12 | 6 | 0.272 | 0.602 | Negative | 25 | 17 | | |
|
|
TNM: tumor node metastasis; and was defined as statistically significant.
|